Elidentus - Company finances
|
EUR
|
2023
From: 2023-01-11
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 57,955 | 76,080 | 96,750 |
| Profit before tax | 40,954 | 33,960 | 63,065 |
| Net profit | 40,954 | 32,262 | 59,281 |
| Equity | 41,054 | 73,316 | 132,597 |
| Liabilities | 1,644 | 11,854 | 11,187 |
| Non-current assets | 1,404 | 1,053 | 702 |
| Current assets | 41,294 | 84,117 | 143,082 |
| Total assets | 42,698 | 85,170 | 143,784 |
|
Taxes paid
|
|||
| STI taxes | 136 | 16 | 1,698 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +31.3% | +27.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 95.9% | 37.9% | 41.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.8% | 44.0% | 44.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 70.7% | 42.4% | 61.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 70.7% | 44.6% | 65.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 57,955 | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Elidentus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-03 | 2024-04-30 | 193.50 |
| 2024-03-01 | 2024-04-02 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2023-10-03 | 2023-10-31 | 58.63 |
| 2023-08-17 | 2023-09-30 | 1.94 |
Elidentus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Elidentus, MB (company code 306217661) is a small partnership operating in diagnostic imaging services and medical laboratory activities. In 2025, the latest financial year, the company generated revenue of €96.8K, up 27.2% year on year and 66.9% over two years. Net profit reached €59.3K, compared with €32.3K in 2024 and €41.0K in 2023, showing a clear improvement in profitability after a lower result in 2024. The 2025 net profit margin was 61.3%, indicating that the business converted a large share of turnover into earnings.
The balance sheet strengthened materially during the period. Total assets increased from €42.7K in 2023 to €85.2K in 2024 and €143.8K in 2025. Equity rose to €132.6K, while liabilities remained limited at €11.2K, resulting in an equity ratio of 92.2% and debt-to-equity of 0.08. Asset turnover stood at 0.67x in 2025. Return on equity was 44.7% and return on assets 41.2%, reflecting strong profitability relative to the company’s asset base.
The balance sheet strengthened materially during the period. Total assets increased from €42.7K in 2023 to €85.2K in 2024 and €143.8K in 2025. Equity rose to €132.6K, while liabilities remained limited at €11.2K, resulting in an equity ratio of 92.2% and debt-to-equity of 0.08. Asset turnover stood at 0.67x in 2025. Return on equity was 44.7% and return on assets 41.2%, reflecting strong profitability relative to the company’s asset base.